Positions

Selected Publications

Academic Article

Year Title Altmetric
2022 Health-Related Quality of Life in Older Patients With Advanced Heart Failure: Findings From the SUSTAIN-IT Study 2022
2022 Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy 2022
2022 Systemic arterial pulsatility index (SAPi) predicts adverse outcomes in advanced heart failure patients 2022
2022 TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine StudyGenetics in Medicine2022
2021 Temporal trends in characteristics and outcomes associated with in-hospital cardiac arrest: A 20-year analysis (1999– 2018) 2021
2021 The Impact of Adverse Events on Functional Capacity and Quality of Life After HeartWare Ventricular Assist Device ImplantationASAIO Journal.  67:1159-1162. 2021
2021 Examining Adherence and Dose Effect of an Early Palliative Care Intervention for Advanced Heart Failure PatientsJournal of Pain and Symptom Management.  62:471-481. 2021
2021 Pulmonary Artery Proportional Pulse Pressure (PAPP) Index Identifies Patients With Improved Survival From the CardioMEMS Implantable Pulmonary Artery Pressure Monitor 2021
2021 Racial and socioeconomic disparity associates with differences in cardiac DNA methylation among men with end-stage heart failure 2021
2021 Persistent mitral regurgitation after left ventricular assist device: a clinical conundrumESC Heart Failure.  8:1039-1046. 2021
2021 Cardiac sympathetic imaging in heart failure: Is revival possible?Journal of Nuclear Cardiology.  28:86-89. 2021
2021 Caregiver health-related quality of life, burden, and patient outcomes in ambulatory advanced heart failure: A report from revival 2021
2021 Commentary: A problem well put is half solvedJournal of Thoracic and Cardiovascular Surgery2021
2021 Factors associated with health-related quality of life 2 years after left ventricular assist device implantation: Insights from intermacs 2021
2021 Management of reproductive health after cardiac transplantation 2021
2020 Clinical characteristics and outcomes of patients requiring prolonged inotropes after left ventricular assist device implantation 2020
2020 Pedicle flap coverage for infected ventricular assist device augmented with dissolving antibiotic beads: Creation of an antibacterial pocketJournal of Cardiac Surgery.  35:2825-2828. 2020
2020 Effect of an Early Palliative Care Telehealth Intervention vs Usual Care on Patients with Heart Failure: The ENABLE CHF-PC Randomized Clinical TrialJAMA Internal Medicine.  180:1203-1213. 2020
2020 Management of reproductive health in patients with pulmonary hypertension 2020
2020 Association of Patient Health-Related Quality of Life and Caregiver Burden in Older Heart Failure Patients Receiving Advanced Therapies: Findings from the SustainIng QualItY of Life of the Aged: Transplant or Mechanical Support (SustAIn-it) Study 2020
2020 Both Patient and Caregiver Factors are Related to Patient Health-Related Quality of Life before Surgery 2020
2020 Caregiver Comorbidities and Anxiety are Related to Caregiver Quality of Life: Findings from the Sustaining QualIty of Life of the Aged: HT or MCS Study 2020
2020 Clinical Characteristics and Outcomes of Patients Requiring Prolonged Inotropes after Left Ventricular Assist Device Implantation 2020
2020 Did a shared thioredoxin-reductase gene mutation lead to maternal peripartum cardiomyopathy and fatal dilated cardiomyopathy in her son? A case report 2020
2020 Effects of a Telehealth Early Palliative Care Intervention for Family Caregivers of Persons With Advanced Heart Failure: The ENABLE CHF-PC Randomized Clinical TrialJAMA Network Open.  3:e202583. 2020
2020 Health-Related Quality of Life Differs by Pre-Operative Implant Strategy from before through Mid-Term after Surgery: Findings from INTERMACS 2020
2020 Impact of Socioeconomic Factors on Patient Desire for Early LVAD Therapy Prior to Inotrope Dependence: Socioeconomic Factors and Preference for LVADJournal of Cardiac Failure.  26:316-323. 2020
2020 Incidence and Onset of Leukopenia in Adults the First Year after Orthotopic Heart Transplantation 2020
2020 Persistent Mitral Regurgitation after Left Ventricular Assist Device: A Clinical Conundrum 2020
2020 Sustaining Quality of Life of the Aged: Transplant or Mechanical Support (SUSTAIN-IT): Sex Differences for Non-Enrollment 2020
2020 Sustaining Quality of Life of the Aged: Transplant or Mechanical Support (Sustain-It): Caregiver Perceived Burden 2020
2020 American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory supportJournal of Thoracic and Cardiovascular Surgery.  159:865-896. 2020
2020 American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support 2020
2020 Cryoablation during left ventricular assist device implantation: A case report: Ignoramus et Ignorabimus, Sapere Aude 2020
2020 Pathological insights into persistent mitral regurgitation following continuous flow left ventricular assist device implantation 2020
2020 African American Recruitment in Early Heart Failure Palliative Care Trials: Outcomes and Comparison With the ENABLE CHF-PC Randomized TrialJournal of Palliative Care2020
2020 Comorbid Conditions and Health-Related Quality of Life in Ambulatory Heart Failure Patients: REVIVAL (Registry Evaluation of Vital Information for VADs in Ambulatory Life REVIVAL)Circulation: Heart Failure2020
2020 Differences in health-related quality of life by implant strategy: Analyses from the Interagency Registry for Mechanically Assisted Circulatory Support 2020
2020 INTERMACS profiles and outcomes of ambulatory advanced heart failure patients: A report from the REVIVAL Registry 2020
2020 Improvement in kidney function after ventricular assist device implantation and its influence on thromboembolism, hemorrhage, and mortalityASAIO Journal.  268-276. 2020
2020 Variant interpretation for dilated cardiomyopathyCirculation: Genomic and Precision Medicine.  43-51. 2020
2019 Between a rock and a hard place: A high-risk patient with resistance to multiple P2Y12 antagonistsPharmacogenomics.  20:475-481. 2019
2019 Blood pressure in a mechanically assisted circulation: “Heat, spirit, perfection” 2019
2019 Evaluation of flow-modulation approaches in ventricular assist devices using an in-vitro endothelial cell culture model 2019
2019 Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry 2019
2019 Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failureLaboratory Investigation.  99:371-386. 2019
2019 Left ventricular assist device thrombosis- A miodarone-induced hyperthyroidism: Causal link?ASAIO Journal.  65:E18-E20. 2019
2019 Performance of noninvasive assessment in the diagnosis of right heart failure after left ventricular assist deviceASAIO Journal.  65:449-455. 2019
2019 Use of computed tomography in preoperative planning for heartware left ventricular assist device placementASAIO Journal.  65:70-76. 2019
2018 Acute Hemodynamic Effects of Biventricular Pacing After Left Ventricular Assist DeviceJournal of Cardiac Failure.  24:716-718. 2018
2018 Educate, Nurture, Advise, Before Life Ends Comprehensive Heartcare for Patients and Caregivers (ENABLE CHF-PC): Study protocol for a randomized controlled trialTrials.  19. 2018
2018 Corrigendum to “Intracranial Hemorrhage in Patients with a Left Ventricular Assist Device” [World Neurosurgery 113 (2018) e714–e721] (S187887501830408X) (10.1016/j.wneu.2018.02.135))World Neurosurgery.  116:539. 2018
2018 High Right Atrial Pressure and Low Pulse Pressure Predict Gastrointestinal Bleeding in Patients With Left Ventricular Assist DeviceJournal of Cardiac Failure.  24:487-493. 2018
2018 Obstructive sleep apnea in heart failure: Review of prevalence, treatment with continuous positive airway pressure, and prognosisTexas Heart Institute Journal.  45:151-161. 2018
2018 Intracranial Hemorrhage in Patients with a Left Ventricular Assist DeviceWorld Neurosurgery.  113:e714-e721. 2018
2018 Mind-Body Interventions for Individuals With Heart Failure: A Systematic Review of Randomized TrialsJournal of Cardiac Failure.  24:186-201. 2018
2018 Association of pulsatility with gastrointestinal bleeding in a cohort of HeartMate II recipientsASAIO Journal.  64:472-479. 2018
2018 Clinical Impact of Changes in Hemodynamic Indices of Contractile Function During Treatment of Acute Decompensated Heart FailureJournal of Cardiac Failure.  24:43-50. 2018
2017 INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and OutcomesJACC: Heart Failure.  5:703-711. 2017
2017 Discordant Perceptions of Prognosis and Treatment Options Between Physicians and Patients With Advanced Heart FailureJACC: Heart Failure.  5:663-671. 2017
2017 Family caregiving for persons with heart failure at the intersection of heart failure and palliative care: a state-of-the-science reviewHeart Failure Reviews.  22:543-557. 2017
2017 Engaging patients and families to create a feasible clinical trial integrating palliative and heart failure care: Results of the ENABLE CHF-PC pilot clinical trialBMC Palliative Care.  16. 2017
2017 Anticoagulation control in patients with ventricular assist devicesASAIO Journal.  63:759-765. 2017
2016 The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapy 2016
2016 High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry 2016
2016 Ventricular Assist Device in Acute Myocardial InfarctionJournal of the American College of Cardiology.  67:1871-1880. 2016
2016 Infections, arrhythmias, and hospitalizations on home intravenous inotropic therapyAmerican Journal of Cardiology.  117:952-956. 2016
2016 Early implementation of video capsule enteroscopy in patients with left ventricular assist devices and obscure gastrointestinal bleedingASAIO Journal.  62:40-45. 2016
2016 Reduce driveline trauma through stabilization and exit site management: 30 days feasibility results from the multicenter RESIST studyASAIO Journal.  62:240-245. 2016
2015 Predictors of thromboembolic events in patients with ventricular assist deviceASAIO Journal.  61:640-647. 2015
2015 Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart FailureCirculation: Heart Failure.  8:880-886. 2015
2015 Duration of Heart Failure Is an Important Predictor of Outcomes after Mechanical Circulatory SupportCirculation: Heart Failure.  8:953-959. 2015
2015 Reply: Upgrade Ambulatory Extra-Aortic Counterpulsation to Full-Support LVADJACC: Heart Failure.  3:343-344. 2015
2015 Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devicesASAIO Journal.  61:107-109. 2015
2014 Have risk factors for mortality after heart transplantation changed over time? Insights from 19 years of Cardiac Transplant Research Database study 2014
2014 Ambulatory extra-aortic counterpulsation in patients with moderate to severe chronic heart failureJACC: Heart Failure.  2:526-533. 2014
2014 Utility of double-balloon enteroscopy in patients with left ventricular assist devices and obscure overt gastrointestinal bleedingEndoscopy.  46:986-988. 2014
2014 Response to letter regarding article, "outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support: Data from the interagency registry for mechanically assisted circulatory support"Circulation: Heart Failure.  7:696. 2014
2014 Cancer in end-stage heart failure patients supported by left ventricular assist devicesASAIO Journal.  60:609-612. 2014
2014 Circulatory support for shock complicating myocardial infarctionJournal of Invasive Cardiology.  26. 2014
2014 Infection and rejection risk after cardiac transplantation with induction vs. no induction: A multi-institutional studyClinical Transplantation.  28:946-952. 2014
2014 Neurologic aspects of heart transplantationHandbook of Clinical Neurology.  121:1229-1236. 2014
2014 Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support data from the interagency registry for mechanically assisted circulatory supportCirculation: Heart Failure.  7:300-309. 2014
2013 Gastrointestinal bleeding in patients with ventricular assist devices is highest immediately after implantationASAIO Journal.  59:480-485. 2013
2013 Use of retrospectively gated CT angiography to diagnose systolic LVAD inflow obstructionASAIO Journal.  59:542-546. 2013
2013 The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary 2013
2012 Continuous-flow devices and percutaneous site infections: Clinical outcomes 2012
2012 Coronary artery fistula after cardiac transplantationCirculation.  126:2144-2145. 2012
2012 Opportunities for improvement in heart transplantation outcomes for young adults 18 to 35 years of age 2012
2012 Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the seattle heart failure modelASAIO Journal.  58:93-97. 2012
2012 Implantation of the HeartWare HVAD in a child after a recent thromboembolic strokeAnnals of Thoracic Surgery.  93:977-978. 2012
2012 Beyond survival: Recommendations from INTERMACS for assessing function and quality of life with mechanical circulatory support 2012
2011 Total lymphoid irradiation in heart transplantation: Long-term efficacy and survival-an 18-year experienceTransplantation.  92:1159-1164. 2011
2011 Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol 2011
2011 Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation 2011
2011 Mechanical circulatory support: We are halfway thereJournal of the American College of Cardiology.  57:1383-1385. 2011
2011 Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failureAmerican Heart Journal.  161:558-566. 2011
2011 Minimizing infection and rejection death: Clues acquired from 19 years of multi-institutional cardiac transplantation data 2011
2011 Fulminant myocarditis as a late sequela of DRESS: Two casesJournal of The American Academy of Dermatology.  65:889-890. 2011
2011 Use of a vascular plug to percutaneously occlude the outflow conduit of a dysfunctional left ventricular assist device 2011
2011 Use of gated cardiac computed tomography angiography in the assessment of left ventricular assist device dysfunctionASAIO Journal.  57:32-37. 2011
2010 Device related infections: Are we making progress?Journal of Cardiac Surgery.  25:478-483. 2010
2010 Bradycardia and syncope as a presentation of cardiac allograft rejection involving the conducting systemCardiovascular Pathology.  19:117-120. 2010
2010 Balancing rejection and infection with respect to age, race, and gender: Clues acquired from 17 years of cardiac transplantation data 2010
2009 Invasive monitoring in patients with heart failureCurrent Cardiology Reports.  11:159-166. 2009
2009 Safety and Efficacy of Ibutilide in Heart Transplant Recipients 2009
2008 Re-stenosis After Drug-eluting Stents in Cardiac Allograft Vasculopathy 2008
2008 Use of an Intraperitoneal Ventricular Assist Device With a Polytetrafluoroethylene Barrier Decreases Infections 2008
2008 Factors associated with non-adherence to therapy with warfarin in a population of chronic heart failure patients 2008
2008 Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertensionChest.  134:139-145. 2008
2007 The future of implantable hemodynamic monitorsFuture Cardiology.  3:579-582. 2007
2007 Post-Heart Transplant Diastolic Dysfunction Is a Risk Factor for MortalityJournal of the American College of Cardiology.  50:1064-1069. 2007
2006 Disparities by insurance status in quality of care for elderly patients with unstable anginaEthnicity and Disease.  16:799-807. 2006
2006 Acute take-off of the right coronary artery with long intra-aortic wall course presenting as chronic coronary ostium occlusion in a patient with end-stage heart failure 2006
2006 Genetic Polymorphism in Platelet-derived Growth Factor and Vascular Endothelial Growth Factor Are Significantly Associated With Cardiac Allograft Vasculopathy 2006
2006 Implantable hemodynamic monitoring devices in heart failureCurrent Cardiology Reports.  8:187-190. 2006
2006 Rejection with hemodynamic compromise: Objective evidence for efficacy of photopheresis 2006
2006 Native aortic valve insufficiency in patients with left ventricular assist devicesAnnals of Thoracic Surgery.  81. 2006
2005 Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure 2005
2005 The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcomeTransplantation.  80:1019-1025. 2005
2005 Post-operative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: Multi-institutional study of post-operative weight change 2005
2005 Managing device infections: Are we progressing or is infection an insurmountable obstacle?ASAIO Journal.  51:452-455. 2005
2005 Relationship between bridging with ventricular assist device on rejection after heart transplantation 2005
2004 Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device 2004
2003 Influence of race in heart failure and cardiac transplantation: Mortality differences are eliminated by specialized, comprehensive careJournal of Cardiac Failure.  9:80-86. 2003
2001 Flow panel reactive antibody monitoring following heart transplantationTransplantation Proceedings.  33:3295-3297. 2001
2000 Management strategies for heparin-induced thrombocytopenia in heart-transplant candidates: Case report and review of the literature 2000
1999 Carvedilol improves functional class in patients with severe left ventricular dysfunction referred for heart transplantationClinical Transplantation.  13:426-431. 1999
1999 The use of milrinone in pretransplant assessment of patients with congestive heart failure and pulmonary hypertension 1999

Chapter

Year Title Altmetric
2009 Device-Based Patient Management.  404-418. 2009
2008 Role of left ventricular assist devices in acute heart failure syndrome and the future of the replacement heart.  737-747. 2008

Principal Investigator On

  • Dilated Cardiomyopathy (DCM) Research Project  awarded by Ohio State University
  • Precision Medicine for Dilated Cardlomyopathy In European and African Ancestry  awarded by Ohio State University
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by CARDIOMEMS, INC.
  • Private Grant  awarded by VENTRACOR, INC.
  • Private Grant  awarded by VENTRACOR, INC.
  • Private Grant  awarded by CARDIOMEMS, INC.
  • Private Grant  awarded by SUNSHINE HEART, INC.
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by TERUMO HEART, INC
  • Private Grant  awarded by THORATEC CORPORATION
  • Private Grant  awarded by PARACOR MEDICAL, INC.
  • Private Grant  awarded by PARACOR MEDICAL, INC.
  • Private Grant  awarded by EVAHEART, INC.
  • Private Grant  awarded by HEARTWARE, INC.
  • Private Grant  awarded by THORATEC CORPORATION
  • Private Grant  awarded by SUNSHINE HEART, INC.
  • Private Grant  awarded by GAMBRO HEALTHCARE
  • Private Grant  awarded by HEARTWARE, INC.
  • Private Grant  awarded by HEARTWARE, INC.
  • Private Grant  awarded by HEARTWARE, INC.
  • Private Grant  awarded by St. Jude Medical
  • Private Grant  awarded by St. Jude Medical
  • Private Grant  awarded by St. Jude Medical
  • Private Grant  awarded by HEARTWARE, INC.
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by MEDTRONIC, INC.
  • Private Grant  awarded by CORAM LLC
  • Private Grant  awarded by MEDTRONIC, INC.
  • Randomized Evaluation of VAD INterVEntion before Inotropic Therapy (REVIVE-IT)/Registry Evaluation of Vital Information for VADS in Ambulatory Life (REVIVAL)  awarded by University of Michigan
  • Randomized Evaluation of VAD Intervention before Inotropic Therapy (REVIVE-IT) Pilot Trial  awarded by University of Michigan
  • Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support  awarded by Northwestern University
  • Investigator On

  • Assessment of Lavare Cycle Implementation among Patients with Heartware left Ventricular Assist Device Implantation: A Prospective Randomized Controlled Pilot Study  awarded by VANDERBILT UNIVERSITY
  • Cardiovascular Disease Risk Among Breast Cancer Survivors  awarded by American Cancer Society, Inc.
  • Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure—CONNECT-HF  awarded by DUKE CLINICAL RESEARCH INSTITUTE
  • ENABLE: CHF-PC (Comprehensive Heartcare for Patients and Caregivers)  awarded by National Institute of Nursing Research/NIH/DHHS
  • Genomic Analysis of Enhanced Response to Heart Failure Therapy in African America  awarded by University of Pittsburgh The
  • Genomic Classification of the Heart Transplant Endomyocardial Biopsy  awarded by University of California, Los Angeles
  • Long Term Outcome Follow-Up of the RAD001 B253 Study, Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients  awarded by Cedars - Sinai Medical Center
  • Predictors of Thromboembolism and Hemorrhage in Patients on Ventricular Assist Devices  awarded by American Heart Association
  • Private Grant  awarded by LILLY-ICOS, LLC
  • Private Grant  awarded by ZEALAND PHARMA
  • Private Grant  awarded by Gilead Sciences ^
  • Private Grant  awarded by UNITED THERAPEUTICS CORPORATION
  • Private Grant  awarded by UNITED THERAPEUTICS CORPORATION
  • Private Grant  awarded by ACTELION CLINICAL RESEARCH, INC.
  • Private Grant  awarded by Bayer AG
  • Private Grant  awarded by MEDTRONIC, INC.
  • Private Grant  awarded by CARDIOVASCULAR CLINICAL SCIENCE FOUNDATION
  • Private Grant  awarded by INO THERAPEUTICS, INC.
  • Private Grant  awarded by BIOCONTROL MEDICAL
  • Private Grant  awarded by St. Jude Medical
  • Private Grant  awarded by AASTROM BIOSCIENCES, INC.
  • Private Grant  awarded by ABIOMED, INC.
  • Private Grant  awarded by LUNG BIOTECHNOLOGY PBC
  • Private Grant  awarded by Actelion Pharmaceuticals Ltd.
  • Private Grant  awarded by Pfizer Pharmaceuticals
  • Private Grant  awarded by ABBOTT VASCULAR, INC.
  • Private Grant  awarded by ARENA PHARMACEUTICALS, INC.
  • Private Grant  awarded by ARENA PHARMACEUTICALS, INC.
  • Private Grant  awarded by CARDIACASSIST, INC
  • Private Grant  awarded by St. Jude Medical
  • Private Grant  awarded by GENO LLC
  • Private Grant  awarded by GENO LLC
  • Private Grant  awarded by TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D
  • Private Grant  awarded by SENSIBLE MEDICAL INNOVATIONS, LTD.
  • Private Grant  awarded by BELLEROPHON PULSE TECHNOLOGIES LLC
  • Private Grant  awarded by UNITED THERAPEUTICS CORPORATION
  • Private Grant  awarded by UNITED THERAPEUTICS CORPORATION
  • Private Grant  awarded by EIGER BIOPHARMACEUTICALS, INC.
  • Private Grant  awarded by EIGER BIOPHARMACEUTICALS, INC.
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. ^
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. ^
  • Private Grant  awarded by UNITED THERAPEUTICS CORPORATION
  • Private Grant  awarded by UNITED THERAPEUTICS CORPORATION
  • Private Grant  awarded by Pfizer Pharmaceuticals
  • Private Grant  awarded by ZOLL SERVICES, LLC
  • Private Grant  awarded by LUNG BIOTECHNOLOGY PBC
  • Private Grant  awarded by LUNG BIOTECHNOLOGY PBC
  • Private Grant  awarded by LIVANOVA USA, INC.
  • Private Grant  awarded by COMPLEXA, INC.
  • Private Grant  awarded by ARENA PHARMACEUTICALS, INC.
  • Private Grant  awarded by UNITED THERAPEUTICS CORPORATION
  • Private Grant  awarded by UNITED THERAPEUTICS CORPORATION
  • Private Grant  awarded by ARRAY BIOPHARMA
  • Private Grant  awarded by UNITED THERAPEUTICS CORPORATION
  • Private Grant  awarded by LUNG BIOTECHNOLOGY PBC
  • Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction SPIRRIT-HFpEF (SPIRRIT)  awarded by Duke University
  • Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction SPIRRIT-HFpEF"(SPIRRIT)  awarded by Duke University
  • Treatment of Preserved Cardiac Function Heart Failure with an Aldosterine Antagonist (TOPCAT)  awarded by NEW ENGLAND RESEARCH INSTITUTE
  • Education And Training

  • University of Toronto, Internship
  • University of Toronto, Residency
  • Rush Presbyterian-St. Luke's Medical Center, Postdoctoral Fellowship
  • University of British Columbia, Postdoctoral Fellowship
  • Master of Public Health, University of Alabama at Birmingham 2005
  • Doctor of Medicine, University of Toronto 1993
  • Bachelor's Degree in Pharmacy, Pharmaceutical Sciences, and Administration, University of Toronto 1989
  • Full Name

  • Salpy Pamboukian